4.4 Review

Radiotherapy for locally advanced pancreatic ductal adenocarcinoma

Related references

Note: Only part of the references are listed.
Editorial Material Oncology

Ablative Radiotherapy for Patients With Inoperable Pancreas Cancer - Ready for Prime Time?

David P. Horowitz et al.

JAMA ONCOLOGY (2021)

Article Oncology

Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer

Marsha Reyngold et al.

Summary: Ablative radiation therapy following multiagent induction therapy for locally advanced pancreatic cancer is associated with durable locoregional tumor control and favorable survival outcomes. Prospective randomized trials in patients with inoperable LAPC are warranted.

JAMA ONCOLOGY (2021)

Meeting Abstract Oncology

Estimation of the Alpha-beta Ratio for Chemoradiation of Locally Advanced Pancreatic Cancer

P. W. Prior et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Gastroenterology & Hepatology

The role of radiotherapy in locally advanced pancreatic carcinoma

Ruchika Gutt et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)

Article Oncology

DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

Christine A. Iacobuzio-Donahue et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Oncology

Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer

Devin Schellenberg et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)